Skip to content

HTFL HTFL Shares Reserved for Future Issuance Under Stock Plans

Shares Reserved for Future Issuance Under Stock Plans at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
64.8M+5.4%
LiveRamp Holdings, Inc. logo
LiveRamp Holdings, Inc.RAMP
51.4M
Voya Financial logo
Voya FinancialVOYA
5.1M-17.0%
Golub Capital logo
Golub CapitalGBDC
93K0.0%
Provident Financial Services logo
Provident Financial ServicesPFS
2.3M0.0%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
34.9M+12.9%

Other financials

Income statement

See full
Revenue$52.6M+41.3%
Gross profit$42.2M+50.9%
Operating income-$29.5M-68.6%
Net income-$27.4M+15.4%
EPS (diluted)-$0.32+93.9%

Balance sheet

See full
Cash & equivalents$24.4M-78.7%
Total debt$26.3M
Total equity$285.7M+132%
Total assets$344.0M

Cash flow

See full
Operating cash flow-$30.1M-129%
CapEx$1.9M+71.6%
Free cash flow-$32.0M-124%

Valuation

See full
Market cap$2.97B
Enterprise value$2.98B
P/S15.5×

Profitability

See full
Gross margin78.1%+2.4pp
Operating margin-39.7%-4.8pp
Net margin-58.4%-12.1pp
FCF margin-40.1%-2.4pp

Returns & leverage

See full
Return on equity37.1%
Debt / equity0.1×
Current ratio5.6×

Where this comes from

Reported directly by HTFL in its filing.

Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.

The official record: HTFL’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about HTFL's shares reserved for future issuance under stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HTFL's shares reserved for future issuance under stock plans?
HTFL (HTFL) reported shares reserved for future issuance under stock plans of $23.72M in Q1 2026.
What does shares reserved for future issuance under stock plans mean?
This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.